Streetbeat News

Products Services

AZN

AstraZeneca announced that its drug Farxiga has been approved in the U.S. for the treatment of pediatric type-2 diabetes.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 7:02 pm

BMR

DDC

RNA

THMO

TNXP

VRA

U.S. stocks traded higher with the S&P 500 surging around 1%. Crude oil stocks in the U.S. climbed by 3.730 million barrels, contrary to expectations. DDC Enterprise, Beamr Imaging, and Avidity Biosciences saw significant stock price increases, while Tonix Pharmaceuticals, ThermoGenesis Holdings, and Vera Bradley experienced notable declines.

Portfolio Pulse from Avi Kapoor

June 12, 2024 | 6:39 pm

GOOGL

MSFT

NVDA

ORCL

TSLA

Oracle's fiscal Q4 earnings fell short of estimates, but the company emphasized its cloud infrastructure growth and new partnerships with Microsoft, OpenAI, and Google Cloud. Despite weak financials, Oracle's cloud unit is growing rapidly, driven by AI demand. The company expects double-digit revenue growth for fiscal 2025.

Portfolio Pulse from Upwallstreet

June 12, 2024 | 6:38 pm

WDAY

Clemson University has chosen Workday's Financial Management, Human Capital Management, and Strategic Sourcing solutions to drive its digital transformation and improve experiences for faculty, staff, and student workers.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 6:29 pm

LLY

The FDA has granted traditional approval to Selpercatinib for treating advanced RET fusion-positive thyroid cancer in patients aged 2 and older. This drug had previously received accelerated approval in 2020 for patients aged 12 and older.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 6:18 pm

CMPS

CYBN

DRUG

ENVB

MNMD

SEEL

Oregon's pioneering psilocybin industry is struggling to attract customers a year after its launch. Despite the initial excitement, the industry faces challenges such as regulatory hurdles, marketing restrictions, and competition. Some service centers have already closed, and more may follow. Entrepreneurs and facilitators are working to raise awareness and adapt to the competitive market.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 6:07 pm

SONY

Sony has acquired the Alamo Drafthouse movie-theater chain, a move that could strengthen its position in the entertainment industry.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 6:05 pm

DKNG

Needham analyst Bernie McTernan reiterated a Buy rating for DraftKings Inc (NASDAQ:DKNG) with a $60 price target, highlighting its leadership in the $35 billion North American online gambling market. McTernan noted favorable legislative environments and sustainable customer acquisition strategies as key drivers for DraftKings' growth.

Portfolio Pulse from Anusuya Lahiri

June 12, 2024 | 5:57 pm

NKE

Goldman Sachs analyst Brooke Roach reiterated a Buy rating on Nike Inc (NYSE:NKE) with a price target of $118.00. The analyst is optimistic about Nike's innovation portfolio and expects gross margin-led profit expansion into FY25. However, there are concerns about uneven quarterly sales growth and macroeconomic factors. Nike's F4Q earnings result is scheduled for June 27.

Portfolio Pulse from Shivani Kumaresan

June 12, 2024 | 5:55 pm

RUM

Rumble announced that its Rumble Studio now works with OBS, a popular open-source software for video recording and live streaming. This integration could enhance the user experience for content creators on the platform.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 5:53 pm